Old | New | Differences | |
---|---|---|---|
1 | - | An Act | |
2 | - | ENROLLED HOUSE | |
1 | + | ||
2 | + | ||
3 | + | ENGR. H. B. NO. 3041 Page 1 1 | |
4 | + | 2 | |
5 | + | 3 | |
6 | + | 4 | |
7 | + | 5 | |
8 | + | 6 | |
9 | + | 7 | |
10 | + | 8 | |
11 | + | 9 | |
12 | + | 10 | |
13 | + | 11 | |
14 | + | 12 | |
15 | + | 13 | |
16 | + | 14 | |
17 | + | 15 | |
18 | + | 16 | |
19 | + | 17 | |
20 | + | 18 | |
21 | + | 19 | |
22 | + | 20 | |
23 | + | 21 | |
24 | + | 22 | |
25 | + | 23 | |
26 | + | 24 | |
27 | + | ||
28 | + | SENATE FLOOR VERSION | |
29 | + | March 28, 2024 | |
30 | + | ||
31 | + | ||
32 | + | ENGROSSED HOUSE | |
3 | 33 | BILL NO. 3041 By: Stinson of the House | |
4 | 34 | ||
5 | 35 | and | |
6 | 36 | ||
7 | 37 | Stanley of the Senate | |
38 | + | ||
39 | + | ||
8 | 40 | ||
9 | 41 | ||
10 | 42 | ||
11 | 43 | ||
12 | 44 | An Act relating to stem cell research; amending 63 | |
13 | 45 | O.S. 2021, Section 1 -270.2, which relates to | |
14 | 46 | permissible stem cell resear ch and reports to the | |
15 | 47 | Governor and Legislature; adding an exception to the | |
16 | 48 | filing requirement; and providing an effective date . | |
17 | 49 | ||
18 | 50 | ||
19 | 51 | ||
20 | - | ||
52 | + | ||
21 | 53 | ||
22 | 54 | BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: | |
23 | - | ||
24 | 55 | SECTION 1. AMENDATORY 63 O.S. 2021, Section 1 -270.2, is | |
25 | 56 | amended to read as follows: | |
26 | - | ||
27 | 57 | Section 1-270.2 A. For the purposes of the Advancement in Stem | |
28 | 58 | Cell Cures and Therapies Act, "human embryo" means a living organism | |
29 | 59 | of the species Homo sapiens at the earliest stage of development, | |
30 | 60 | including the single-cell stage, that is not located in the body of | |
31 | 61 | a woman. | |
32 | - | ||
33 | 62 | B. Research on human tissue regeneration and human diseases | |
34 | 63 | using adult stem cells and stem cells obtained from umbilical cord | |
64 | + | ||
65 | + | ENGR. H. B. NO. 3041 Page 2 1 | |
66 | + | 2 | |
67 | + | 3 | |
68 | + | 4 | |
69 | + | 5 | |
70 | + | 6 | |
71 | + | 7 | |
72 | + | 8 | |
73 | + | 9 | |
74 | + | 10 | |
75 | + | 11 | |
76 | + | 12 | |
77 | + | 13 | |
78 | + | 14 | |
79 | + | 15 | |
80 | + | 16 | |
81 | + | 17 | |
82 | + | 18 | |
83 | + | 19 | |
84 | + | 20 | |
85 | + | 21 | |
86 | + | 22 | |
87 | + | 23 | |
88 | + | 24 | |
89 | + | ||
35 | 90 | blood and amniotic fluid may be conducted in this state, provided | |
36 | 91 | that the research is performed: | |
37 | - | ||
38 | 92 | 1. Safely and ethically; | |
39 | - | ||
40 | 93 | 2. Only on embryonic stem cell lines created prior to August 1, | |
41 | 94 | 2001, and in accordance with federal law as it existed on November | |
42 | 95 | 1, 2007; and | |
43 | - | ||
44 | 96 | 3. Without the use of a human embryo, including a huma n embryo | |
45 | 97 | produced using cloning technology. | |
46 | - | ENR. H. B. NO. 3041 Page 2 | |
47 | 98 | C. When research is performed in accordance with the | |
48 | 99 | Advancement in Stem Cell Cure s and Therapies Act, a person or | |
49 | 100 | governmental body shall not: | |
50 | - | ||
51 | 101 | 1. Restrict public funds designated for the stem cell research; | |
52 | 102 | or | |
53 | - | ||
54 | 103 | 2. Obstruct or provide disincentives for the stem cell | |
55 | 104 | research. | |
56 | - | ||
57 | 105 | D. The State Department of Health shall establish a reporting | |
58 | 106 | system that collects information regarding all activities carried | |
59 | 107 | out in accordance with this section. | |
60 | - | ||
61 | 108 | E. The Department shal l submit a report with all information | |
62 | 109 | collected pursuant to subsection D of this section to the Governor, | |
63 | 110 | the Speaker of the O klahoma House of Representatives, and the | |
64 | 111 | President Pro Tempore of the Oklahoma State Senate no later than | |
65 | 112 | December 31 of each ye ar. | |
66 | 113 | ||
114 | + | ENGR. H. B. NO. 3041 Page 3 1 | |
115 | + | 2 | |
116 | + | 3 | |
117 | + | 4 | |
118 | + | 5 | |
119 | + | 6 | |
120 | + | 7 | |
121 | + | 8 | |
122 | + | 9 | |
123 | + | 10 | |
124 | + | 11 | |
125 | + | 12 | |
126 | + | 13 | |
127 | + | 14 | |
128 | + | 15 | |
129 | + | 16 | |
130 | + | 17 | |
131 | + | 18 | |
132 | + | 19 | |
133 | + | 20 | |
134 | + | 21 | |
135 | + | 22 | |
136 | + | 23 | |
137 | + | 24 | |
138 | + | ||
67 | 139 | F. Provided that there is no stem cell research to report that | |
68 | 140 | year, the Department does not need to file a report. | |
69 | - | ||
70 | 141 | SECTION 2. This act shall become effective November 1, 2024. | |
71 | - | ENR. H. B. NO. 3041 Page 3 | |
72 | - | Passed the House of Representatives the 12th day of March, 2024. | |
73 | - | ||
74 | - | ||
75 | - | ||
76 | - | ||
77 | - | Presiding Officer of the House | |
78 | - | of Representatives | |
79 | - | ||
80 | - | ||
81 | - | ||
82 | - | Passed the Senate the 17th day of April, 2024. | |
83 | - | ||
84 | - | ||
85 | - | ||
86 | - | ||
87 | - | Presiding Officer of the Senate | |
88 | - | ||
89 | - | ||
90 | - | OFFICE OF THE GOVERNOR | |
91 | - | Received by the Office of the Governor this _________________ ___ | |
92 | - | day of ___________________, 20_______, at _______ o'clock _______ M. | |
93 | - | By: _________________________________ | |
94 | - | Approved by the Governor of the State of Oklahoma this _____ ____ | |
95 | - | day of ___________________, 20_______, at _______ o'clock _______ M. | |
96 | - | ||
97 | - | ||
98 | - | _________________________________ | |
99 | - | Governor of the State of Oklahoma | |
100 | - | ||
101 | - | OFFICE OF THE SECRETARY OF STATE | |
102 | - | Received by the Office of the Secretary of State this __________ | |
103 | - | day of ___________________, 20_______, at _______ o'clock _______ M. | |
104 | - | By: _________________________________ | |
105 | - | ||
142 | + | COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVIC ES | |
143 | + | March 28, 2024 - DO PASS |